Antiretrovirals and the kidney in current clinical practice
Authors:
- Anton PozniakAPAnton Pozniak
- Marta BoffitoMBMarta Boffito
- Rachael JonesRJRachael Jones
- Saye KhooSKSaye Khoo
- Jeremy LevyJLJeremy Levy
- Frank A. PostFPFrank A. Post
- 13 March 2014
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 28 (5) , 621-632
Abstract
Assessment of renal function in HIV-positive patients is of increasing importance in the context of ageing and associated comorbidities. Exposure to nephrotoxic medications is widespread, and several commonly used antiretroviral drugs have nephrotoxic potential. Moreover, specific antiretrovirals inhibit renal tubular transporters resulting in the potential for drug-drug interactions as well as increases in serum creatinine concentrations, which affect estimates of glomerular filtration rate in the absence of changes in actual glomerular filtration rate. This review explores the effects of antiretroviral therapy on the kidney and offers an understanding of mechanisms that lead to apparent and real changes in renal function.Keywords
This publication has 94 references indexed in Scilit:
- Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D StudyaThe Journal of Infectious Diseases, 2013
- Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive PatientsAmerican Journal of Kidney Diseases, 2012
- Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavirAIDS, 2012
- Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavirAIDS, 2011
- Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular DysfunctionThe Journal of Infectious Diseases, 2011
- Kidney function and the risk of cardiovascular events in HIV-1-infected patientsAIDS, 2010
- Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and AccumulationAntimicrobial Agents and Chemotherapy, 2009
- Rapid Clinical Induction of Hepatic Cytochrome P4502B6 Activity by RitonavirAntimicrobial Agents and Chemotherapy, 2008
- Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney diseaseAIDS, 2008
- Mechanism of Active Renal Tubular Efflux of TenofovirAntimicrobial Agents and Chemotherapy, 2006